Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.64, $0.05 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $616.2 million versus the consensus estimate of $558.78 million.

"Based on the strength of first-quarter results and our initiatives for the remainder of the year, we are increasing our annual revenue guidance by $70 million," said Wood. "We remain focused on building momentum and executing our customer growth strategy by increasing social sharing capabilities with additional training and tools, driving innovation with ageLOC LumiSpa and other new products, and continuing the roll out of Velocity, our enhanced sales compensation program."

"We generated 24 percent year-over-year revenue growth and strong earnings performance in the quarter," said Mark Lawrence, chief financial officer. "As previously disclosed, we incurred a charge associated with the early conversion of our convertible note, which was not included in our original guidance and negatively impacted first-quarter earnings by $0.12 per share. In addition, due to purchase accounting, we incurred a $0.03 charge related to the amortization of intangibles from our recent acquisitions.

"For the year, we are increasing our annual revenue guidance to $2.51 billion to $2.56 billion with earnings per share of $3.45 to $3.65. This earnings guidance reflects the $0.12 negative impact related to the convertible note and approximately $0.16 of estimated amortization of intangibles from the acquisitions which were not included in our previous guidance. The most significant impact of the amortization will be in 2018. We are projecting second-quarter revenue of $630 to $650 million and earnings per share of $0.86 to $0.91," concluded Lawrence.

GUIDANCE:

Nu Skin Enterprises sees FY2018 EPS of $3.45-$3.65, versus the consensus of $3.62. Nu Skin Enterprises sees FY2018 revenue of $2.51-2.56 million, versus the consensus of $2.47 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.